Use of Mifepristone and Sublingual Misoprostol for Early Medical Abortion
نویسندگان
چکیده
منابع مشابه
Comparison or oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion.
BACKGROUND & OBJECTIVE Medical abortion though legalized in India, is still not very popular. A disadvantage of medical abortion is the longer duration of bleeding compared with surgical abortion which may reduce acceptability. Due consideration needs to be given to the issues related to medical abortion for improving the reproductive health status of women suffering from consequences of unsafe...
متن کاملMifepristone-misoprostol medical abortion: home administration of misoprostol in Guadeloupe.
Mifepristone-misoprostol medical abortion promises to revolutionize reproductive health-care. Several simplifications of the standard three clinic visit regimen may be possible, however. Particularly in developing countries, access to the method can be greatly increased by eliminating the longest clinic visit. Indeed, shortly after mifepristone's introduction in Guadeloupe, a semi-developed Car...
متن کاملAlternatives to mifepristone for early medical abortion.
OBJECTIVE To review published reports of first-trimester medical abortion regimens that do not include mifepristone. METHODS Reports listed in Pubmed and Medline on prospective and controlled trials of the efficacy of misoprostol, alone or associated with methotrexate, for first-trimester abortion were analyzed if they included more than 100 participants and were published since 1990. RESUL...
متن کاملDifferent Time Schedules of Mifepristone and Misoprostol in Second Trimester Medical Abortion: A Comparative Study
Background & aim: Recently, the use of mifepristone followed by misoprostol after 36-48 h has been demonstrated to be an effective and safe method for the second trimester medical abortion. However, this regimen entails long total abortion time, and consequently increases the financial burden and anxiety in the patients. We hypothesize that one day interval would be also effective and can be us...
متن کاملMifepristone and misoprostol for early medical abortion: 18 months experience in the United States.
In the first 18 months since mifepristone was approved by the Food and Drug Administration (FDA) for use with misoprostol for early medical abortion, approximately 80,000 women have been treated. One-hundred thirty-nine adverse events were reported to Danco Laboratories LLC and subsequently reported to the FDA. Thirteen patients required blood transfusions, 10 patients were treated with antibio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Taiwanese Journal of Obstetrics and Gynecology
سال: 2006
ISSN: 1028-4559
DOI: 10.1016/s1028-4559(09)60251-5